CAH
Price
$149.24
Change
+$1.75 (+1.19%)
Updated
Aug 27 closing price
Capitalization
35.64B
64 days until earnings call
COR
Price
$290.56
Change
+$0.86 (+0.30%)
Updated
Aug 27 closing price
Capitalization
56.33B
70 days until earnings call
Interact to see
Advertisement

CAH vs COR

Header iconCAH vs COR Comparison
Open Charts CAH vs CORBanner chart's image
Cardinal Health
Price$149.24
Change+$1.75 (+1.19%)
Volume$2.3M
Capitalization35.64B
Cencora
Price$290.56
Change+$0.86 (+0.30%)
Volume$880.17K
Capitalization56.33B
CAH vs COR Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. COR commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and COR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (CAH: $149.24 vs. COR: $290.56)
Brand notoriety: CAH and COR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 86% vs. COR: 68%
Market capitalization -- CAH: $35.64B vs. COR: $56.33B
CAH [@Medical Distributors] is valued at $35.64B. COR’s [@Medical Distributors] market capitalization is $56.33B. The market cap for tickers in the [@Medical Distributors] industry ranges from $85.02B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 1 FA rating(s) are green whileCOR’s FA Score has 3 green FA rating(s).

  • CAH’s FA Score: 1 green, 4 red.
  • COR’s FA Score: 3 green, 2 red.
According to our system of comparison, COR is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 4 TA indicator(s) are bullish while COR’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 4 bullish, 5 bearish.
  • COR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CAH and COR are a good buy in the short-term.

Price Growth

CAH (@Medical Distributors) experienced а -2.43% price change this week, while COR (@Medical Distributors) price change was -4.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.00%. For the same industry, the average monthly price growth was +4.45%, and the average quarterly price growth was -1.83%.

Reported Earning Dates

CAH is expected to report earnings on Oct 31, 2025.

COR is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Distributors (+1.00% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($56.3B) has a higher market cap than CAH($35.6B). COR has higher P/E ratio than CAH: COR (29.83) vs CAH (23.14). COR YTD gains are higher at: 30.106 vs. CAH (27.582). COR has higher annual earnings (EBITDA): 4.02B vs. CAH (3.11B). CAH has more cash in the bank: 3.87B vs. COR (2.23B). COR (8.24B) and CAH (8.53B) have identical debt. COR has higher revenues than CAH: COR (317B) vs CAH (223B).
CAHCORCAH / COR
Capitalization35.6B56.3B63%
EBITDA3.11B4.02B77%
Gain YTD27.58230.10692%
P/E Ratio23.1429.8378%
Revenue223B317B70%
Total Cash3.87B2.23B174%
Total Debt8.53B8.24B103%
FUNDAMENTALS RATINGS
CAH vs COR: Fundamental Ratings
CAH
COR
OUTLOOK RATING
1..100
6562
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
9912
PRICE GROWTH RATING
1..100
5451
P/E GROWTH RATING
1..100
8430
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (64) in the Medical Distributors industry is in the same range as COR (74) in the Real Estate Investment Trusts industry. This means that CAH’s stock grew similarly to COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is in the same range as CAH (4) in the Medical Distributors industry. This means that COR’s stock grew similarly to CAH’s over the last 12 months.

COR's SMR Rating (12) in the Real Estate Investment Trusts industry is significantly better than the same rating for CAH (99) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than CAH’s over the last 12 months.

COR's Price Growth Rating (51) in the Real Estate Investment Trusts industry is in the same range as CAH (54) in the Medical Distributors industry. This means that COR’s stock grew similarly to CAH’s over the last 12 months.

COR's P/E Growth Rating (30) in the Real Estate Investment Trusts industry is somewhat better than the same rating for CAH (84) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHCOR
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
50%
Momentum
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
57%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
41%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
37%
Bearish Trend 3 days ago
40%
Advances
ODDS (%)
Bullish Trend 15 days ago
65%
Bullish Trend 9 days ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
40%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
52%
Aroon
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ISCV66.960.53
+0.79%
iShares Morningstar Small-Cap Value ETF
DMO11.850.07
+0.59%
Western Asset Mortgage Opportunity Fund
VTHR286.100.89
+0.31%
Vanguard Russell 3000 ETF
IAUG27.620.01
+0.03%
Innovator Intl Dev Pwr Bffr ETF - Aug
OVF28.15-0.08
-0.27%
Overlay Shares Foreign Equity ETF

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+1.19%
MCK - CAH
58%
Loosely correlated
+0.44%
COR - CAH
56%
Loosely correlated
+0.30%
SHTDF - CAH
12%
Poorly correlated
N/A
EDAP - CAH
9%
Poorly correlated
+3.95%
HSIC - CAH
9%
Poorly correlated
-0.12%
More

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
+0.30%
MCK - COR
66%
Loosely correlated
+0.44%
CAH - COR
51%
Loosely correlated
+1.19%
SHTDF - COR
17%
Poorly correlated
N/A
OMI - COR
13%
Poorly correlated
-2.40%
EDAP - COR
12%
Poorly correlated
+3.95%
More